Number of the records: 1
kináza anaplastického lymfómu
SYS d000077548 LBL 00000cz--a2200181n--4500 005 20250606222649.9 008 190101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 $d BA006 065 $a D08.811.913.696.620.682.725.400.002 065 $a D12.776.476.568.400.002 065 $a D12.776.543.750.630.002 066 $a 01 $c 03 150 $a kináza anaplastického lymfómu $x AD $x AG $x AI $x AN $x BI $x BL $x CH $x CL $x DE $x DF $x GE $x HI $x IM $x IP $x ME $x PH $x RE $x TU $x UL $2 slo 450 $w v $a ALK kináza $2 slo 450 $w v $a ALK tyrozínkinázový receptor $2 slo 450 $w v $a tyrozínkináza anaplastického lymfómu, receptorová $2 slo 450 $w v $a CD246 antigén $2 slo 450 $w v $a NPM-ALK $2 slo 450 $w v $a nukleofozmín – kináza anaplastického lymfómu $2 slo 450 $w v $a nukleofosmín – kináza anaplastického lymfómu $2 slo 665 $a 2019 (1994) $2 eng 680 9-
$i A receptor tyrosine kinase that is essential for development and differentiation of the nervous system in response to secreted growth factors. It phosphorylates the first tyrosine of the Y-x-x-x-Y-Y motif of targets that include PROTO-ONCOGENE PROTEINS C-CBL; INSULIN RECEPTOR SUBSTRATE-1; and MITOGEN-ACTIVATED PROTEIN KINASES, leading to activation of the MAPK signaling pathway and cell proliferation. A chromosomal aberration involving the ALK gene results in its constitutive expression in some cases of NON-HODGKIN LYMPHOMA. $2 eng 750 -2
$a Anaplastic Lymphoma Kinase $2 eng 980 $x M
Number of the records: 1